.jpg)
Opinion: Commissioner Califf needs to put the F back in FDA
Robert Califf is taking the reins as commissioner of the Food and Drug Administration with…
Category: advocacy
Opinion: The U.S. must fix its innovation engine: the patent system
If your car starts to smoke and sputter, you’d take it to an auto repair…
Opinion: Politicians should not be deciding what constitutes good medicine
Most people get their medical advice from their doctors. But many may soon get it…
Opinion: Sunsetting medical license reciprocity would return medicine to the dark ages
Like many other 3-year-old boys, Braxton Davis is lively and at times playfully mischievous. But…
Opinion: Health care workers don unnecessary protective gear. The CDC and WHO need to update their PPE guidance
Every time we enter a Covid patient’s room, we first don gloves, and a disposable…
Opinion: Turning to social media to get affordable insulin: a clear sign of a broken health care system
I am part of an underground market for drugs that looks a lot different from…
Opinion: Rediscovering a language of healing that doesn’t require ‘cure’
I am a biotech investor and entrepreneur. But more central to my worldview is that…
Opinion: A ‘more, more, more’ approach to cancer screening is misleading and harmful
Enormous progress has been made against cancer in the last 50 years — at least…
Opinion: To restore public trust, the CDC must stop legitimizing the expulsion of asylum seekers
The Centers for Disease Control and Prevention has come under fire in past weeks over…
Opinion: The case for Califf: Don’t let politics prevent confirmation of best FDA commissioner candidate
President’s Biden’s nomination of Robert Califf to head the Food and Drug Administration is in…
Covid-19 politics force state lawmakers to ponder pharma campaign cash
WASHINGTON — Ohio state Rep. Beth Liston had accepted campaign donations from Pfizer before, but…
Opinion: Confessions of a ‘human guinea pig’: Why I’m resigning from Moderna vaccine trials
In July 2020, I volunteered to be in Moderna’s Covid-19 vaccine trial. If I knew…
Opinion: Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices?
Astellas Pharma, a drug company headquartered in Japan, is charging U.S. patients $156,000 a year…
Opinion: Deaths of despair: the unrecognized tragedy of working class immiseration
Given the socioeconomic effects of the ongoing Covid-19 pandemic, it should have come as no…
Opinion: Nuclear Regulatory Commission’s foot-dragging on patient irradiation suggests regulatory capture
Government agencies responsible for protecting the public from negligence and harm must act with independence…
Opinion: At a time when the U.S. needed Covid-19 dialogue between scientists, Francis Collins moved to shut it down
This week, emails released through a Freedom of Information Act request filed by the American…
Opinion: Listen: Looking back on the first year of ‘First Opinion Podcast’
We started the “First Opinion Podcast” in February 2021 because we knew there was rich,…
Opinion: Listen: A parent on advocating for people with autism who can’t advocate for themselves
Alison Singer learned how to advocate for a child with autism by watching her mother…
Opinion: FDA’s outdated Birth Control Guide blocks access to the innovations the agency has approved
Every day, women in the United States are routinely denied access to the latest birth…
Opinion: STAT+: Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help
Against declining trust in traditional news sources and institutions that provide data and information, the…
Opinion: Forensic medical examinations are key to helping asylum seekers prove trauma
After a decade of horrific abuse by her husband, Ms. A. felt she had no…
Opinion: Ending the pandemic requires global solidarity, not blame
When historians write about the Covid-19 pandemic, they will certainly highlight the essential research behind…
Opinion: Listen: A public health expert passes on football’s full body collisions for youth
If there was one moment that led Kathleen Bachynski to a career studying the public…
Opinion: Labels can harm, but they also can help: See ‘profound autism’
Labels are a divisive subject. When used inappropriately, they have the power to misrepresent and…
STAT+: Major telehealth players unite ahead of tough lobbying battle
WASHINGTON — Major players in the telehealth space have united to create a supergroup of…
Opinion: Why two emergency physicians’ kids took part in the Pfizer vaccine trials
Cue the collective sigh of relief from many parents across the country. While the Pfizer-BioNTech…
Opinion: Listen: A patient and a nephrologist on how using race in kidney testing puts lives at risk
Ever since medicine adopted a race-based formula to assess kidney health in the mid-2000s, some…
Opinion: I’m almost always the only Hmong American scientist in the room. Yet I was told I come from a group overrepresented in STEM
I grew up in a small, low-income community surrounded by diverse groups of people, including…
Opinion: What Moderna owes the world
Moderna is expected to reveal its third quarter earnings on Nov. 4. The announcement will…
STAT+: The loudest physician proponents of Aduhelm have all taken money from Biogen
WASHINGTON — A small group of physicians with deep, at times undisclosed, financial ties to…
Which drug maker spent the most on lobbying this summer? The answer will surprise you
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Opinion: Don’t give Covid-19 long-haulers the silent treatment
“I feel like I’m getting the silent treatment and it’s killing me,” Pamela Bishop confided…
STAT+: Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs
Phoenix, Ariz. is no Kendall Square. Its biotech companies, ventures like OncoMyx Therapeutics and VisionGate,…
STAT+: Amazon is beefing up its health care lobbying operation
WASHINGTON — Amazon is bulking up its efforts to influence health care policy at the…
.jpg)
Listen: An Alzheimer’s scholar on the paradox of declining dementia rates
Although billions of dollars have been poured into potential pharmaceutical cures for dementia, particularly Alzheimer’s…
Opinion: On a day to celebrate the Nobel in medicine, a stain still mars the institute that awards it
As the Nobel Assembly at Sweden’s Karolinska Institute announces the winners of the 2021 Nobel…
Opinion: Enough pink: We’re doing Breast Cancer Awareness Month all wrong
October is upon us, which means the world is about get a whole lot more…
STAT+: Big business lobbies bitterly divided over drug pricing reform
WASHINGTON — Groups representing companies like Apple, Tesla, and Boeing are clashing with Washington’s wealthiest…
STAT+: ‘A solid black eye’: Drug pricing reform advocates scramble to reset after setback in Congress
WASHINGTON — For the cadre of progressive groups fighting to bring down drug prices in…
Opinion: STAT+: A 10-point plan for sustaining the biopharma industrial base for a more secure nation
Covid-19 has underscored the critical role the biopharma industrial base plays in the U.S.’s national…
Opinion: ‘This Is My Story’: connecting clinicians with hospitalized patients who can’t speak for themselves
During the maelstrom of Covid-19 in April 2020, I assisted in a birth at Johns…
STAT+: ‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby
WASHINGTON — The Biotechnology Innovation Organization, the lobbying group that represents roughly 1,000 biotech companies,…
Opinion: I was once a hardcore anti-vaxxer. Now I try to nudge people to get the Covid-19 vaccine
I open the email from a Facebook friend who recently told me they were against…
Opinion: Listen: A father describes the legacy of his son’s ultra-rare disease
Bertrand Might was born with a rare disease that had never before been diagnosed, an…
Opinion: Delay of British chronic fatigue syndrome guidelines are a setback for people with long Covid
The National Institute for Health and Care Excellence (NICE), a British agency charged with developing…
Opinion: Booster shots alone won’t protect immunocompromised people from Covid-19
Covid-19 taught me something about second chances: In March 2020, I fought the virus and…
Opinion: Doctors pledge to do no harm. The entire health care sector should do the same by battling climate change
The alarming new report, “Climate Change 2021,” from the U.N. Intergovernmental Panel on Climate Change…
Opinion: Harm-reduction programs acknowledge the difference between ‘do no harm’ and ‘protect from harm’
Brian, a patient at my clinic in Scott County, Ind., is one of many who…
Billions in new research funding sparks a lobbying frenzy among patient advocates
WASHINGTON — President Biden’s vision for an ambitious new government research center is never quite…
Opinion: Listen: A longtime glioblastoma survivor on how to keep surviving
In this week’s episode of the “First Opinion Podcast,” writer and philosopher Adam Hayden opens…